Astrana Health 3Q 2026: Revenue $1.02B, EPS $0.26 — 10-Q Summary
Astrana Health reported 3Q 2026 revenue of $1.02B, up 7% YoY, and net income of $13.0M, compared to $373K last year. Growth was driven by 9% increase in capitation revenue. Care Partners saw 8% revenue growth and 94% operating income rise, while Care Delivery revenue increased 5% but operating loss widened. Care Enablement revenue rose 5% with 4% higher operating income. Astrana managed 29 IPAs and 1.5M patients as of September 30, 2026.
How this was made

The 30-second read
Why it matters
The earnings beat may trigger short‑term buying and could set a higher baseline for future guidance.
Market read
First‑report earnings data for Astrana Health provides actionable insight for traders focusing on health‑services equities.
What to watch
Rising operating costs in Care Delivery could pressure margins if patient‑visit growth slows.
Background
Astrana Health is a U.S. managed‑care company that recently transitioned many enrollees to full‑risk contracts (RKKs).
Ticker impact
Astrana Health reported Q3 2026 revenue of $1.02B and EPS $0.26, a fresh earnings disclosure.
likely upside as investors price in the earnings beat and higher profitability
Revenue rose 7% YoY and net income jumped from $0.373M to $13.0M, indicating improved margins and operational execution.
Market effects
Highlights strength in the managed‑care and capitation revenue segment, potentially benefiting peers in health‑services.
U.S. health‑services sector may see modest buying pressure.
Limited to U.S. health‑services investors; no broader macro effect.
Counterpoint
If guidance falls short of market expectations despite the earnings beat, the stock could face disappointment.
Key entities
- companyAstrana Health, Inc.
Issuer of the Q3 2026 earnings report.



